Sign up here for our daily coronavirus newsletter on what you need to know, andsubscribe to our Covid-19 podcast for the latest news and analysis.
As evidence grows that a century-oldtuberculosis vaccine can protect against respiratory infections, the Netherlands will begin testing it on thousands of frail elderly people who are at elevated risk in the coronavirus pandemic.
Two new studies point to promising results for thebacillus Calmette-Guerin shot, or BCG, against Covid-19, though research evaluating the vaccine’s direct potential against the new virus is months away from publishing results.
One study, led byMihai Netea of Radboud University Medical Center in the Netherlands, shows that elderly people who were vaccinated with BCG are 80% less likely than those without shots to get a respiratory tract infection. Another in a group of hospital workers in the United Arab Emirates shows those who got the shot didn’t catch Covid-19, unlike an unvaccinated control group.
78,357 in IndiaMost new cases today
+3% Change in MSCI World Index of global stocks since Wuhan lockdown, Jan. 23
-1.055 Change in U.S. treasury bond yield since Wuhan lockdown, Jan. 23
5.4% Global GDP Tracker (annualized), July